Dacarbazine Injection, Powder, For Solution
Product Images NDC 63323-128

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Dacarbazine (NDC 63323-128). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Dac02 0000 01)

Chemical structure diagram of the active ingredient dacarbazine, showing its molecular components and bonds in a clear two-dimensional format.*

FDA Label Image

Logo (Dac02 0000 02)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Dacarbazine 100 mg Vial Label)

Dacarbazine 100 mg injection powder for solution vial label. The label states it is prepared as the citrate salt for intravenous use only, single dose vial. The label includes storage instructions, shelf life after reconstitution, and manufacturer Fresenius Kabi USA, LLC information along with lot, expiration, and reconstitution fields.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY)

Dacarbazine 100 mg injection label for intravenous use, prepared as the citrate salt. The product comes in single-dose vials, 10 vials of 10 mL each. Labeled by Fresenius Kabi USA, LLC, with storage instructions and barcode visible. Contains directions to discard unused portion and notes vial stoppers do not contain natural rubber latex.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Dacarbazine 200 mg Vial Label)

Dacarbazine 200 mg injection powder for solution, prepared as the citrate salt in a single-dose vial. Label indicates it is for intravenous use only, sterile, and for prescription use. Storage instructions include refrigeration at 2-8°C and protection from light. Labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Dacarbazine 200 mg Tray Label)

Label for Dacarbazine injection, USP 200 mg prepared as the citrate salt in powder form for solution. The product is for intravenous use only, supplied in 10 single-dose vials of 20 mL each. Manufactured by Fresenius Kabi USA, LLC. Storage instructions and other usage details are also included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.